Artículo

Antiparasitic Activity of Two Natural Terpenes from Salvia cuspidata against Leishmania amazonensis

Troncoso, Mariana Elizabeth Icon; Germano, Maria Jose Icon; Arrieta, Victoria Judith Icon; Garcia Bustos, Maria Fernanda Icon; Cifuente, Diego Alberto Icon; Cargnelutti, Diego Esteban Icon; Lozano, Esteban Sebastián Icon

Otros responsables

Fecha

03/2023

Editorial

American Chemical Society

Revista

Journal of Natural Products

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

0163-3864

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

Leishmaniasis is a neglected disease caused by flagellated parasites of the Leishmania genus affecting more than 10 million people worldwide. Current treatments for leishmaniasis involve the administration of poorly tolerated drugs with toxic side effects in patients. There is an imperative necessity for novel compounds to treat this disease. One of the most used strategies in the search for different antiparasitic compounds is the screening of purified plant molecules. The diterpenes 12-hydroxy-11,14-diketo-6,8,12-abietatrien-19,20-olide (HABTO) and 5-epi-icetexone (ICTX) isolated from Salvia cuspidata were shown to be effective against Leishmania amazonensis in vitro and in vivo. They displayed an antiproliferative effect against L. amazonensis promastigotes. They also induce an increase in ROS levels and affect the mitochondrial activity of parasites. HABTO and ICTX in an in vivo model of cutaneous leishmaniasis decrease footpad swelling, parasite load, and splenic index. Moreover, they induce significant reduction in the O.D. of total anti-Leishmania IgG and IgG1 subtype antibody responses against L. amazonensis compared to the PBS group but maintain high levels of IgG2a. This suggests that in HABTO- or ICTX-treated mice, there is a slowdown in the progression of the disease. These terpenes could be considered as possible novel antileishmanial agents against L. amazonensis and thus treat cutaneous leishmaniasis.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa